Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.966 on 09-10-2026 at 18:25:07
Change $0.00 0%
Buy $0.968
Sell $0.966
Last Trade: Sell 55,421.00 at $0.966
Day's Volume: 655,061
Last Close: $0.966
Open: $0.964
ISIN: GB00BDGKMY29
Day's Range $0.964 - $0.97
52wk Range: $0.876 - $1.00
Market Capitalisation: $1.08b
VWAP: $0.966173
Shares in Issue: 1.12b

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 55,421 $0.966 Uncrossing Trade
16:35:14 - 09-Oct-26
Unknown* 1,031 $0.967 Ordinary
16:26:04 - 09-Oct-26
Sell* 2,646 $0.966 Automatic Execution
16:21:16 - 09-Oct-26
Sell* 50,000 $0.966 Automatic Execution
16:21:16 - 09-Oct-26
Buy* 2,234 $0.968 Automatic Execution
16:15:39 - 09-Oct-26
Sell* 45,956 $0.966 Automatic Execution
16:05:14 - 09-Oct-26
Sell* 1,800 $0.966 Automatic Execution
16:05:14 - 09-Oct-26
Buy* 19,598 $0.966 Automatic Execution
16:05:08 - 09-Oct-26
Buy* 19,395 $0.966 Automatic Execution
16:05:08 - 09-Oct-26
Buy* 26,561 $0.966 Automatic Execution
16:05:08 - 09-Oct-26
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
9th Oct 2026 (Fri) 0.964 0.97 0.964 0.966 655,061
8th Oct 2026 (Thu) 0.968 0.97 0.962 0.966 1,207,099
7th Oct 2026 (Wed) 0.978 0.984 0.978 0.98 2,150,086
6th Oct 2026 (Tue) 0.976 0.99 0.976 0.978 655,382
5th Oct 2026 (Mon) 0.976 0.984 0.976 0.984 489,024
2nd Oct 2026 (Fri) 0.974 0.984 0.974 0.98 1,364,688
1st Oct 2026 (Thu) 0.976 0.982 0.974 0.978 1,547,931
30th Sep 2026 (Wed) 0.99 0.99 0.974 0.98 2,550,827
29th Sep 2026 (Tue) 0.98 0.99 0.98 0.984 992,013
28th Sep 2026 (Mon) 0.98 0.986 0.98 0.984 935,731
25th Sep 2026 (Fri) 0.978 0.982 0.976 0.982 2,299,749
24th Sep 2026 (Thu) 0.97 0.98 0.968 0.972 815,230
23rd Sep 2026 (Wed) 0.97 0.972 0.966 0.97 367,434
22nd Sep 2026 (Tue) 0.968 0.972 0.968 0.97 1,200,770
21st Sep 2026 (Mon) 0.972 0.972 0.966 0.97 3,155,206
18th Sep 2026 (Fri) 0.972 0.976 0.966 0.97 848,042
17th Sep 2026 (Thu) 0.97 0.974 0.968 0.974 812,914
16th Sep 2026 (Wed) 0.972 0.972 0.966 0.97 4,431,533
15th Sep 2026 (Tue) 0.97 0.97 0.966 0.966 477,188
14th Sep 2026 (Mon) 0.97 0.97 0.962 0.966 970,405
11th Sep 2026 (Fri) 0.966 0.974 0.966 0.972 724,302
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
30th Sep 2026 4:33 pm RNS Dividend Declaration
30th Sep 2026 4:21 pm RNS Director/PDMR Shareholding
24th Sep 2026 7:00 am RNS Half-year Financial Report
23rd Sep 2026 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
23rd Sep 2026 12:17 pm RNS Holding(s) in Company
15th Sep 2026 1:03 pm RNS Directorate change
3rd Sep 2026 3:08 pm RNS-R QuotedData's In The HotSeat
26th Aug 2026 10:00 am RNS Notice of Half Year Results
24th Aug 2026 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
20th Aug 2026 7:00 am RNS Completion of Lumira Sale
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

DIRECTOR DEALINGS: Seplat's Elumelu buys GBP53 million in shares

6th Oct 2026 11:47

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced in the last two weeks and not separately reported by Alliance News: Read More

BioPharma Credit expects pipeline growth as net asset value edges down

24th Sep 2026 11:16

(Alliance News) - BioPharma Credit PLC on Thursday said its net asset value edged lower in the first half of 2026, as the company continued to invest in new life sciences opportunities. Read More

UK earnings, trading statements calendar - next 7 days

17th Sep 2026 14:20

Read More

TRADING UPDATES: Theracryf's fund raise; Potter & Moore sales struggle

20th Aug 2026 20:06

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

LONDON BRIEFING: JD cuts guidance; Standard Life expands UK pensions

20th Aug 2026 07:59

(Alliance News) - JD Sports Fashion lowers its annual profit guidance after weak second-quarter trading. Standard Life unveils a GBP2 billion-backed partnership to expand its UK pension risk transfer business, while Hays swings to an annual loss. Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value10,552.05
Change110.45

Login to your account

Forgot Password?

Not Registered